Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Operating activities:
Net loss	$ (1,018,550)	$ (273,754)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	758,564	725,584
Stock-based compensation	45,981	36,178
Non-cash life insurance policy accretion	(75,216)	(66,248)
Deferred income taxes	(89,000)	(142,000)
Foreign currency transaction (gain)/loss	98,172	56,195
(Increase) decrease in accounts receivable and accounts due from employees and distributors	163,256	(96,078)
(Increase) decrease in inventories	(585,634)	79,760
(Increase) decrease in refundable income taxes	(214,378)	(234,219)
(Increase) decrease in prepaid expenses and other current assets	(123,423)	(190,337)
(Increase) decrease in other assets	23,247	(11,501)
Increase (decrease) in income taxes payable	0	(199,558)
Increase (decrease) in accounts payable & accrued expenses and other noncurrent liabilities	(86,860)	(403,554)
Net cash used in operating activities	(1,103,841)	(719,532)
Investing activities:
Proceeds from the sale of property, plant and equipment	7,181	1,200
Purchase of property, plant and equipment	(224,719)	(511,227)
Payments received on distributor note receivable	72,088	67,900
Payment of life insurance premiums	0	(252,250)
Net cash used in investing activities	(145,450)	(694,377)
Financing activities:
Proceeds from line of credit borrowings	0	500,000
Repayment of line of credit borrowings	(500,000)	0
Proceeds from term loan borrowings	3,249,501	0
Principal payments on long-term borrowings	(3,334,552)	(508,899)
Net cash used in financing activities	(585,051)	(8,899)
Effect of exchange rate changes on cash and cash equivalents	3,915	(55,391)
Increase (decrease) in cash and cash equivalents	(1,830,427)	(1,478,199)
Cash and cash equivalents at beginning of period	4,989,392	6,656,798
Cash and cash equivalents at end of period	3,158,965	5,178,599
Noncash financing transactions (Note 5):
Issuance of promissory notes	424,000	0
Issuance of company common stock	$ 117,000	$ 0